ABSTRACT
Nonmelanoma skin cancers (NMSCs), the majority of which encompass basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs), outnumber all other malignancies combined.1 In 2012, greater than 5.4 million cases of NMSC were diagnosed in the United States, which represented a 35% increase in incidence over 6 years.1 One in four NMSC is treated with Mohs micrographic surgery (MMS), a specialized surgical procedure indicated for skin cancers with high-risk features or occurring on functionally or cosmetically sensitive areas.2
